Sheffield Children's NHS Foundation Trust

sheffieldchildrens.nhs.uk

Total trials

51

Active

10

Phase 3

1

Total enrollment

2,964

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 3 of 3 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
dexamethasone1
nasal Tetracosactide1
IV tetracosactide1

Next readouts

  • 2025-12-01
  • 2026-08-31

Top conditions

  • Fractures, Bone3
  • Bone Fracture2
  • Sleep Apnea2
  • Osteogenesis Imperfecta2
  • Fracture2
  • Duchenne Muscular Dystrophy1
  • Constipation1
  • Abdominal Pain1

Frequently asked questions about Sheffield Children's NHS Foundation Trust

How many clinical trials does Sheffield Children's NHS Foundation Trust have on ClinicalTrials.gov?
Sheffield Children's NHS Foundation Trust is listed as the lead sponsor on 51 clinical trials in ClinicalTrials.gov, 10 of which are currently active (recruiting, enrolling, or ongoing).
How many of Sheffield Children's NHS Foundation Trust's trials are in Phase 3?
1 of Sheffield Children's NHS Foundation Trust's trials are in Phase 3, spread across 3 active drug programs.
What therapeutic areas does Sheffield Children's NHS Foundation Trust focus on?
Sheffield Children's NHS Foundation Trust's most-studied conditions on ClinicalTrials.gov are Fractures, Bone, Bone Fracture, Sleep Apnea, Osteogenesis Imperfecta, Fracture.
When are Sheffield Children's NHS Foundation Trust's next clinical trial readouts?
Sheffield Children's NHS Foundation Trust has 2 upcoming primary-completion readouts tracked here; the soonest is “NeSST2: The Development of a Noninvasive Short Synacthen Test”, expected around 2025-12-01.